FDA Inspection
Catalent Maryland IncCatalent Maryland Inc – FDA Inspection, Mar 10, 2023
Record Details
This FDA Inspection record concerns Catalent Maryland Inc, with an inspection on March 10, 2023, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · 910b7e32-3345-4b0c-9787-67d795d90c40
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1207147
- FDA center
- Biologics
- Project area
- Vaccines and Allergenic Products
- Outcome
- Form 483 issued
Other FDA inspections of Catalent Maryland Inc
4| Date | Classification | Office | Project area |
|---|---|---|---|
| April 28, 2025 | Not classified | Baltimore District Office | |
| November 15, 2024 | Not classified | Baltimore District Office | |
| January 24, 2023 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| November 17, 2021 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Catalent Maryland Inc
- FDA Inspection 1276283 - 2025-04-28
- FDA Inspection 1252977 - 2024-11-15
- FDA Inspection 1197573 - 2023-01-24
- FDA Inspection 1156961 - 2021-11-17
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.